Home
HelpTest Code AMPHE AMPHETAMINES SCREEN WITH GC-MS CONFIRMATION, URINE
Additional Codes
| Software | Test Code |
|---|---|
| Label Text | AMPHE |
| EPIC | LAB10888 |
Performing Laboratory
NorDx Laboratories
Useful For
The screening assay detects amphetamine and/or methamphetamine in urine with minimal cross reactivity to various over the counter amphetamine-like compounds.
Method Name
Enzyme Immunoassay (EIA)
Gas Chromatography-Mass Spectrometry (GC-MS) (If indicated)
Reference Values
Not Detected
EIA screening cutoff concentration: 500 ng/mL
GC-MS cutoff concentrations:
Amphetamine: < 100 ng/mL
Methamphetamine: <100 ng/mL
MDMA (Ecstasy): < 100 ng/mL
MDA (Ecstasy metabolite): < 100 ng/mL
MDEA: < 100 ng/mL
For help with interpretation please call: 877-323-0045
Days and Times Test Performed
Monday through Friday
Report Available
1 Day
If Negative
Specimen Type
Urine, Random
Preferred Container
Urine Cup
Preferred Volume
Urine, Random: 25 mL (Urine Cup)
Minimum Volume
Urine, Random: 10 mL (Urine Cup)
Specimen Collection and Handling
Collect random urine and send refrigerated in a clean, non-sterile urine container.
Add On Capable
Not Permitted
Advance Beneficiary Notice Requirements
This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.
CPT Code Information
|
CPT Code |
CPT Description |
CPT Disclaimer |
|---|---|---|
| 80307 | Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry) | |
| 80326 | Amphetamines, 5 or more (Definitive Drug Testing), Quantitative | if Indicated |
| G0480 | Drug Test (Definitive), 1-7 Classes | Government Payers, if Applicable |
| G0481 | Drug Test (Definitive), 8-14 Classes | Government Payers, if Applicable |
| G0482 | Drug Test (Definitive), 15-21 Classes | Government Payers, if Applicable |
| G0483 | Drug Test (Definitive), 22+ Classes | Government Payers, if Applicable |
Performing Laboratory Location
NorDx Laboratories
Maximum Laboratory Time
4 Days
LOINC Code Information
19343-3
Clinical Significance
If the amphetamines screen is ≥ 500 ng/mL, the amphetamines confirmation/quantitation by GC-MS is performed at an additional charge.
INTENDED POSITIVES:
Amphetamine, dextroamphetamine, lisdexamfetamine (Adderall, Dexedrine, DextroStat, LiQuadd, ProCentra, Vyvanse, Speed)
Benzphetamine (Didrex)
Methamphetamine (Desoxyn, Crank, Crystal, Ice, Meth)
Methylenedioxyamphetamine (MDA), Methylenedioxymethamphetamine (Ecstasy, MDMA)
Phentermine (Adipex-P, Ionamin, Pro-Fast)
POSSIBLE UNINTENDED POSITIVES:
Levmetamfetamine (Vicks vapor Inhaler)
Selegine (Eldepryl, Emsam, Zelapar)
Trazodone (Desyrel, Desyrel Dividose, Oleptro, Trazodone D)
This test is intended for clinical monitoring and management of patients. It is not intended for non-medical use such as employment or forensic testing.
Specific gravity, pH, creatinine and oxidants will be performed and reported at no additional charge to identify potential adulteration of the urine specimen.